Inventor
THOMAS ANDREW PETER
GB39 patents
⚠️ This page may combine multiple inventors who share the name “THOMAS ANDREW PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTRAZENECA AB
18 patentsUS6908920B2Jun 21, 2005
Pyrimidine derivatives
ASTRAZENECA AB124 citations96
US7173038B1Feb 6, 2007
Quinazoline derivatives as VEGF inhibitors
ASTRAZENECA AB24 citations92
US6855719B1Feb 15, 2005
Imidazo[1,2-A]pyridine and pyrazolo[2,3-A]pyridine derivatives
ASTRAZENECA AB90 citations92
US7737149B2Jun 15, 2010
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
ASTRAZENECA AB17 citations91
US6969714B2Nov 29, 2005
Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
ASTRAZENECA AB18 citations84
US6844341B2Jan 18, 2005
Pyrimidine derivatives for inhibition of cell proliferation
ASTRAZENECA AB17 citations84
US7579349B2Aug 25, 2009
4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
ASTRAZENECA AB19 citations83
US6906065B2Jun 14, 2005
4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
ASTRAZENECA AB10 citations74
US6939872B2Sep 6, 2005
2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
ASTRAZENECA AB9 citations73
US9688640B2Jun 27, 2017
Methods of treating cancer with a pyrazole derivative
ASTRAZENECA AB2 citations71
US9040548B2May 26, 2015
Quinazoline derivatives as VEGF inhibitors
ASTRAZENECA AB1 citations62
US7485638B2Feb 3, 2009
Pyrimidine compounds
ASTRAZENECA AB4 citations62
US7465728B2Dec 16, 2008
Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
ASTRAZENECA AB3 citations62
US7427626B2Sep 23, 2008
2-Anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their use as cdk (cdk2) inhibitors
ASTRAZENECA AB1 citations52
US10301267B2May 28, 2019
Compounds
ASTRAZENECA AB0 citations51
US7446105B2Nov 4, 2008
Pyrimidine compounds
ASTRAZENECA AB1 citations51
US7442697B2Oct 28, 2008
4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity
ASTRAZENECA AB1 citations51
US7579344B2Aug 25, 2009
Pyrimidine derivatives possessing cell-cycle inhibitors activity
ASTRAZENECA AB1 citations50
ZENECA LTD
14 patentsUS6362336B1Mar 26, 2002
Chemical compounds
ZENECA LTD115 citations99
US5962458AOct 5, 1999
Substituted quinazolines
ZENECA LTD156 citations99
US6809097B1Oct 26, 2004
Quinoline derivatives inhibiting the effect of growth factors such as VEGF
ZENECA LTD76 citations98
US6514971B1Feb 4, 2003
Cinnoline derivatives and use as medicine
ZENECA LTD84 citations98
US6294532B1Sep 25, 2001
Oxindolylquinazoline derivatives as angiogenesis inhibitors
ZENECA LTD87 citations98
US6265411B1Jul 24, 2001
Oxindole derivatives
ZENECA LTD95 citations98
US6184225B1Feb 6, 2001
Quinazoline derivatives as VEGF inhibitors
ZENECA LTD112 citations98
US6414148B1Jul 2, 2002
Quinazoline derivatives and pharmaceutical compositions containing them
ZENECA LTD96 citations97
US6673803B2Jan 6, 2004
Quinazoline derivatives and pharmaceutical compositions containing them
ZENECA LTD68 citations96
US6291455B1Sep 18, 2001
4-anilinoquinazoline derivatives
ZENECA LTD56 citations96
US6258951B1Jul 10, 2001
Chemical compounds
ZENECA LTD72 citations96
US6071921AJun 6, 2000
Chemical compounds
ZENECA LTD58 citations96
US5821246AOct 13, 1998
Aniline derivatives
ZENECA LTD128 citations95
US5880130AMar 9, 1999
4,6-dianilino-pyrimidine derivatives, their preparation and their use as tyrosine kinase inhibitors
ZENECA LTD12 citations74
ASTRAZENECA UK LTD
2 patentsFOOTE KEVIN MICHAEL
2 patentsUS8129391B2Mar 6, 2012
N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof
FOOTE KEVIN MICHAEL12 citations90
US8604022B2Dec 10, 2013
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof
FOOTE KEVIN MICHAEL8 citations82